Funds and ETFs Ascendis Pharma A/S

Equities

ASND

US04351P1012

Biotechnology & Medical Research

Real-time Estimate Cboe BZX 02:19:06 2024-06-27 pm EDT 5-day change 1st Jan Change
133.7 USD +0.77% Intraday chart for Ascendis Pharma A/S +9.70% +5.93%

ETFs positioned on Ascendis Pharma A/S

Ascendis Pharma A/S is a Denmark-based company that manufactures pharmaceutical products. The Company produces products for the treatments of growth hormone deficiency, endocrinology, central nervous system disorders, infectious diseases, and diabetes. The Company operates globally though its subsidiaries: Ascendis Pharma GmbH (Germany), Ascendis Pharma, Inc. (Delaware, United States), Ascendis Pharma Endocrinology, Inc. (Delaware, United States), Ascendis Pharma, Ophthalmology Division A/S (Denmark), Ascendis Pharma, Endocrinology Division A/S (Denmark), Ascendis Pharma Bone Diseases A/S (Denmark), Ascendis Pharma Growth Disorders A/S (Denmark) and Ascendis Pharma Oncology Division A/S (Denmark).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
124.2 EUR
Average target price
170.7 EUR
Spread / Average Target
+37.40%
Consensus
  1. Stock Market
  2. Equities
  3. ASND Stock
  4. Funds and ETFs Ascendis Pharma A/S